MX9603606A - N-metil-n-[(1s)-1-fenil-2-((3s)-3-hidroxipirrolidin-1-il) etil]-2,2-difenil-acetamida. - Google Patents
N-metil-n-[(1s)-1-fenil-2-((3s)-3-hidroxipirrolidin-1-il) etil]-2,2-difenil-acetamida.Info
- Publication number
- MX9603606A MX9603606A MX9603606A MX9603606A MX9603606A MX 9603606 A MX9603606 A MX 9603606A MX 9603606 A MX9603606 A MX 9603606A MX 9603606 A MX9603606 A MX 9603606A MX 9603606 A MX9603606 A MX 9603606A
- Authority
- MX
- Mexico
- Prior art keywords
- phenyl
- hydroxypirrolidin
- acetamide
- ethyl
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19531464A DE19531464A1 (de) | 1995-08-26 | 1995-08-26 | N-Methyl-N-[(1S-)-1-phenyl-2-((3S)-3-hydroxypyrrolidin 1-yl-)-ethyl]-2,2-diphenyl-acetamid |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9603606A true MX9603606A (es) | 1997-03-29 |
Family
ID=7770485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9603606A MX9603606A (es) | 1995-08-26 | 1996-08-23 | N-metil-n-[(1s)-1-fenil-2-((3s)-3-hidroxipirrolidin-1-il) etil]-2,2-difenil-acetamida. |
Country Status (25)
Country | Link |
---|---|
US (1) | US6060504A (ko) |
EP (1) | EP0761650B1 (ko) |
JP (3) | JP5023273B2 (ko) |
KR (1) | KR100436254B1 (ko) |
CN (1) | CN1081631C (ko) |
AR (1) | AR004679A1 (ko) |
AT (1) | ATE207895T1 (ko) |
AU (1) | AU716615B2 (ko) |
BR (1) | BR9603540A (ko) |
CA (1) | CA2184049C (ko) |
CZ (1) | CZ287783B6 (ko) |
DE (2) | DE19531464A1 (ko) |
DK (1) | DK0761650T3 (ko) |
ES (1) | ES2165948T3 (ko) |
HU (1) | HU226667B1 (ko) |
MX (1) | MX9603606A (ko) |
NO (1) | NO307048B1 (ko) |
PL (1) | PL187691B1 (ko) |
PT (1) | PT761650E (ko) |
RU (1) | RU2174976C2 (ko) |
SI (1) | SI0761650T1 (ko) |
SK (1) | SK282437B6 (ko) |
TW (1) | TW513407B (ko) |
UA (1) | UA41978C2 (ko) |
ZA (1) | ZA967200B (ko) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1828399A (en) * | 1997-12-22 | 1999-07-12 | Alza Corporation | Novel formulations for the transdermal administration of asimadoline |
DE19827633A1 (de) * | 1998-04-20 | 1999-10-21 | Merck Patent Gmbh | Verfahren zur Herstellung von enantiomerenreinem N-Methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamid |
US6174878B1 (en) * | 1999-08-31 | 2001-01-16 | Alcon Laboratories, Inc. | Topical use of kappa opioid agonists to treat otic pain |
DE10116978A1 (de) * | 2001-04-05 | 2002-10-10 | Merck Patent Gmbh | Kappa-Opiatagonisten für die Behandlung von Erkrankungen der Blase |
AU2003242527B2 (en) * | 2002-05-17 | 2008-10-23 | Tioga Pharmaceuticals, Inc. | Use of compounds that are effective as selective opiate receptor modulators |
DE10259245A1 (de) * | 2002-12-17 | 2004-07-01 | Merck Patent Gmbh | Derivate des Asimadolins mit kovalent gebundenen Säuren |
CA2544245A1 (en) * | 2003-10-30 | 2005-05-26 | Tioga Pharmaceuticals, Inc. | Use of selective opiate receptor modulators in the treatment of neuropathy |
EP2136801B1 (en) | 2007-03-30 | 2012-08-29 | Tioga Pharmaceuticals, Inc. | Kappa-opiate agonists for the treatment of diarrhea-predominant and alternating irritable bowel syndrome |
EP2284987B1 (en) * | 2009-08-12 | 2019-02-06 | Braun GmbH | Method and device for adjusting the frequency of a drive current of an electric motor |
MX2012011604A (es) * | 2010-04-07 | 2013-02-27 | Onyx Therapeutics Inc | Inhibidor de inmunoproteasoma de péptido epoxicetona cristalino. |
US9675587B2 (en) | 2013-03-14 | 2017-06-13 | Allergan Holdings Unlimited Company | Opioid receptor modulator dosage formulations |
CN103664727A (zh) * | 2013-12-19 | 2014-03-26 | 无锡万全医药技术有限公司 | 一种一锅法制备1-[(3s)-3-羟基吡咯烷-1-基]-(2s)-2-甲氨基-2-苯基乙烷的工艺 |
WO2018119108A1 (en) | 2016-12-21 | 2018-06-28 | Tioga Pharmaceuticals Inc. | Splid pharmaceutical formulations of asimadoline |
EP3932390A1 (en) | 2020-07-02 | 2022-01-05 | Dr. August Wolff GmbH & Co. KG Arzneimittel | Topical gel formulation containing asimadoline |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4215213A1 (de) * | 1992-05-09 | 1993-11-11 | Merck Patent Gmbh | Arylacetamide |
-
1995
- 1995-08-26 DE DE19531464A patent/DE19531464A1/de not_active Withdrawn
-
1996
- 1996-08-02 DE DE59608050T patent/DE59608050D1/de not_active Expired - Lifetime
- 1996-08-02 EP EP96112489A patent/EP0761650B1/de not_active Expired - Lifetime
- 1996-08-02 ES ES96112489T patent/ES2165948T3/es not_active Expired - Lifetime
- 1996-08-02 SI SI9630392T patent/SI0761650T1/xx unknown
- 1996-08-02 DK DK96112489T patent/DK0761650T3/da active
- 1996-08-02 PT PT96112489T patent/PT761650E/pt unknown
- 1996-08-02 AT AT96112489T patent/ATE207895T1/de active
- 1996-08-16 CZ CZ19962434A patent/CZ287783B6/cs not_active IP Right Cessation
- 1996-08-19 AU AU62149/96A patent/AU716615B2/en not_active Ceased
- 1996-08-21 UA UA96083322A patent/UA41978C2/uk unknown
- 1996-08-22 SK SK1089-96A patent/SK282437B6/sk not_active IP Right Cessation
- 1996-08-22 JP JP22129696A patent/JP5023273B2/ja not_active Expired - Fee Related
- 1996-08-23 RU RU96116925/04A patent/RU2174976C2/ru not_active IP Right Cessation
- 1996-08-23 MX MX9603606A patent/MX9603606A/es unknown
- 1996-08-23 CN CN96111404A patent/CN1081631C/zh not_active Expired - Fee Related
- 1996-08-23 TW TW085110305A patent/TW513407B/zh not_active IP Right Cessation
- 1996-08-23 CA CA002184049A patent/CA2184049C/en not_active Expired - Fee Related
- 1996-08-23 ZA ZA967200A patent/ZA967200B/xx unknown
- 1996-08-23 AR ARP960104088A patent/AR004679A1/es not_active Application Discontinuation
- 1996-08-23 PL PL96315799A patent/PL187691B1/pl not_active IP Right Cessation
- 1996-08-23 NO NO963526A patent/NO307048B1/no not_active IP Right Cessation
- 1996-08-23 BR BR9603540A patent/BR9603540A/pt active Search and Examination
- 1996-08-24 KR KR1019960035289A patent/KR100436254B1/ko not_active IP Right Cessation
- 1996-08-26 US US08/703,350 patent/US6060504A/en not_active Expired - Lifetime
- 1996-08-26 HU HU9602346A patent/HU226667B1/hu not_active IP Right Cessation
-
2008
- 2008-10-02 JP JP2008257423A patent/JP2009046501A/ja active Pending
-
2012
- 2012-09-18 JP JP2012204622A patent/JP2012246321A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9602683A (es) | Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas. | |
AU2614995A (en) | Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies | |
MXPA03007712A (es) | Sales farmaceuticas. | |
ATE255410T1 (de) | Arzneimittel, das clodronat als wirkstoff und mit siliciumdioxid behandelte mikrokristalline cellulose als füllstoff enthält | |
YU57600A (sh) | Derivarti biciklične hidroksaminske kiseline | |
MX9603606A (es) | N-metil-n-[(1s)-1-fenil-2-((3s)-3-hidroxipirrolidin-1-il) etil]-2,2-difenil-acetamida. | |
MX9605023A (es) | Compuestos substituidos de imidazolidin-2,4-diona como substancias farmaceuticamente activas. | |
MY124695A (en) | Novel composition and use. | |
CA2325739A1 (en) | Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a nmda receptor complex modulator | |
CA2047744A1 (en) | Method for the synthesis of huperzine a and analogs thereof and compounds useful therein | |
HK1039273A1 (en) | Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient | |
AU6611696A (en) | N-(4-substituted-benzyl)-2-aminolactam derivatives | |
CA2350659A1 (en) | Pharmaceutical composition for modified release insulin sensitiser | |
AU7270798A (en) | Antithrombotic agents | |
NO954952L (no) | Fremgangsmåte for fremstilling av en oral fast-stoff doseringsform som inneholder diklofenac | |
MX9708394A (es) | Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion. | |
AU2003271811A1 (en) | Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulphonates) and compositions containing same | |
AU7775398A (en) | Novel glycosylated ginkgolide derivatives, their application as medicines and pharmaceutical compositions | |
CA2344686A1 (en) | High purity composition comprising (7.alpha.,17.alpha.)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one | |
MX9709453A (es) | Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion. | |
CA2386423A1 (en) | Pharmaceutical compositions containing copper, salicylic acid and vitamines c | |
AU7470098A (en) | Antithrombotic agents | |
GR1002576B (el) | Φαρμακευτικες συνθεσεις και μια μεθοδος παρασκευης τους. | |
YU48200A (sh) | Farmaceutski preparati | |
ZA986730B (en) | Streptogramin derivatives their preparation and compositions containing them |